Back
State Street SPDR S&P Pharmaceuticals ETF Vs. LeMaitre Vascular, Inc. Industry Stock Comparison
Buy
65
XPH
State Street SPDR S&P Pharmaceuticals ETF
Last Price:
$54.59
Seasonality Move:
3.02%
Buy
60
LMAT
LeMaitre Vascular, Inc.
Last Price:
$108.31
Seasonality Move:
9.89%
Buy
65
State Street SPDR S&P Pharmaceuticals ETF (XPH)
is a Buy
Is State Street SPDR S&P Pharmaceuticals ETF a Buy, Sell or Hold?
-
The current State Street SPDR S&P Pharmaceuticals ETF [XPH] share price is $54.72. The Score for XPH is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
XPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
LeMaitre Vascular, Inc. (LMAT)
is a Buy
Is LeMaitre Vascular, Inc. a Buy, Sell or Hold?
-
The current LeMaitre Vascular, Inc. [LMAT] share price is $108.49. The Score for LMAT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
LMAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XPH Stock Price Chart
What is State Street SPDR S&P Pharmaceuticals ETF's stock price today?
-
The State Street SPDR S&P Pharmaceuticals ETF share price today is $54.72The current trend is relatively stagnant and XPH is experiencing slight buying pressure.
LMAT Stock Price Chart
What is LeMaitre Vascular, Inc.'s stock price today?
-
The LeMaitre Vascular, Inc. share price today is $108.49The current trend is moderately bullish and LMAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
XPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 52 | Buy |
| Chaikin Money Flow: | 19896 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.73 - 55.85) | Buy |
| Bollinger Bands (100): | (53.01 - 57.27) | Sell |
LMAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.47 | Buy |
| Relative Strength Index (14 RSI): | 56.35 | Buy |
| Chaikin Money Flow: | 74546 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (106.9 - 110.22) | Sell |
| Bollinger Bands (100): | (81.37 - 102.13) | Buy |
XPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.3 | Buy |
| 20-day SMA: | 53.74 | Buy |
| 50-day SMA: | 55.63 | Sell |
| 200-day SMA: | 50.28 | Buy |
| 8-day EMA: | 53.68 | Buy |
| 20-day EMA: | 54.01 | Buy |
| 50-day EMA: | 54.79 | Sell |
| 200-day EMA: | 51.39 | Buy |
LMAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 108.91 | Sell |
| 20-day SMA: | 108.9 | Sell |
| 50-day SMA: | 98.64 | Buy |
| 200-day SMA: | 90.01 | Buy |
| 8-day EMA: | 108.6 | Sell |
| 20-day EMA: | 107.27 | Buy |
| 50-day EMA: | 101.1 | Buy |
| 200-day EMA: | 91.91 | Buy |
State Street SPDR S&P Pharmaceuticals ETF Earnings Growth & XPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
LeMaitre Vascular, Inc. Earnings Growth & LMAT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.01 per share, an increase this year of $0.48 per share, and an increase next year of $0.28 per share.
State Street SPDR S&P Pharmaceuticals ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
LeMaitre Vascular, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||